Loading clinical trials...
Loading clinical trials...
Primary Objective is the tolerability and safety of ascending single and repeated intravenous infusion (IV) and/or subcutaneous (SC) administration of SAR441344
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanofi
NCT05545306 · Obesity, Normal Physiology, and more
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
NCT00104325 · Healthy Volunteers
NCT07118891 · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
NCT01399385 · Healthy, Obesity, and more
PPD-Site Number:8400001
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions